Results 26 - 50 from 89 for "zentiva"
-
Zentiva Group Reports RON1.05B Sales in Romania in 2020
04.29.2021
Generics manufacturer Zentiva Group on Thursday reported sales of around RON1.05 billion in Romania in 2020, of which its factory in Bucharest generated RON558 million, 1% lower than in 2020, the more
-
Zentiva Climbs to Third Place Among Pharmaceutical Companies by Sales in Romania in 2020
03.04.2021
The strategy adopted at the onset of the pandemic to boost production capacity for drugs in demand drove local pharmaceutical manufacturer Zentiva to third place among the largest pharmaceutical more
-
Zentiva Net Profit Doubles YoY To RON41M In 1H/2020
08.21.2020
Pharmaceutical producer Zentiva Romania (SCD.RO) registered a turnover of RON281 million in the first half of 2020, close to the RON284.9 million level reported in the same period in 2019, per the more
-
Zentiva Romania Posts RON46.3M Profit in 2019
04.30.2020
Pharmaceutical producer Zentiva Romania (SCD.RO), 95.9% owned by Czech Zentiva Group, said Thursdy its turnover grew 16% in 2019, to RON535.4 million, and it made a profit of RON46.3 million. more
-
Zentiva Completes Acquisition of Alvogen's CEE Operations Including Romanian Labormed
04.07.2020
Zentiva Group, owned by Advent International, announced Tuesday it has completed the acquisition of Alvogen's Central and Eastern European (CEE) business. more
-
Zentiva Group Buys Alvogen’s Operations In CEE, Including Labormed Plant In Romania
10.25.2019
-
Zentiva Appoints New Provisional Director
10.01.2019
Pharmaceutical producer Zentiva (SCD.RO), owned by Czech Zentiva Group, said Tuesday it has appointed Kenneth Lynard as provisional director as of October 1, following the resignation of Blery Carol more
-
Zentiva Boosts Share Capital By RON28M To RON69.7M
09.09.2019
-
Zentiva 1H Net Profit Grows 36%, to RON49M
08.14.2019
Pharmaceutical producer Zentiva Romania (SCD.RO), 95.9% owned by Czech Zentiva Group, on Wednesday reported a net profit of RON48.9 million, up 36% on the year. more
-
Zentiva Gets Antitrust Clearance to Buy Solacium Brand from A&D Pharma
05.28.2019
Romania's antitrust body has cleared the deal whereby generics manufacturer Zentiva, owned by Advent International, took over the Romanian food supplement brand Solacium from A&D Pharma, owned by Dr. more
-
Zentiva Net Profit Nearly Triples in 1Q, To RON32.5M
05.15.2019
Generics manufacturer Zentiva on Wednesday reported a net profit of RON32.5 million for the first quarter, nearly triple compared with the RON12 million net profit posted in the same period of 2018. more
-
Zentiva Invests Over RON27M In Generic Drug Production In 2018
05.02.2019
-
Zentiva Net Profit Nearly Triples in 2018, to RON247M
02.28.2019
Generics manufacturer Zentiva on Thursday reported a net profit of RON247 million for 2018, nearly triple compared with a profit of RON86 million in 2017. more
-
Czech Zentiva Launches Mandatory Takeover Bid For Remaining 6.7% Stake In Zentiva Bucharest
12.13.2018
Czech group Zentiva is launching a mandatory takeover bid for the remaining 6.7% stake in drugmaker Zentiva Bucharest (the former Sicomed), at a price of nearly RON105 million, which enables Zentiva more
-
Zentiva Pharmaceutical Plant Could Go To Indian Company
03.14.2018
The generics division of French-held Sanofi, which includes the Zentiva pharmaceutical company with its plant in Romania (the former Sicomed), as well, is being courted by India’s Torrent more
-
Generics Manufacturer Zentiva Posts Net Profit of RON43M in 1H/2017
08.01.2017
Zentiva Bucharest (SCD.RO), a unit of France’s pharmaceutical group Sanofi, on Tuesday reported a net profit of RON43 million for the first six months of 2017, higher than the RON32.4 million profit more
-
Zentiva Posts 10% Higher Turnover, Of RON110.2M, 9% Lower Operating Profit In 1Q/2017
05.12.2017
-
Zentiva Bucharest Pays Out Dividends At 6.5% Yield
04.28.2017
Zentiva Bucharest (SCD.RO), a unit of France’s pharmaceutical group Sanofi, will pay dividends of RON65 million from last year’s profit of RON73 million, the company said Friday. more
-
Zentiva Plans To Pay Out Dividends At 8% Yield, Targets RON16M Investments In 2017
03.23.2017
Zentiva Bucharest (SCD.RO), a unit of France’s pharmaceutical group Sanofi, plans to pay out a gross dividend of RON0.155 per share, which equals a yield of nearly 8%, considering the current price more
-
Zentiva Posted Turnover Of RON415M, Net Profit Of RON72M In 2016
02.15.2017
-
Zentiva Profit Up 36% To RON52.5M In January-September
11.14.2016
Zentiva Bucharest (SCD.RO), a unit of France’s pharmaceutical group Sanofi, reported a net profit of RON52.5 million in January-September 2016, up 36% against the year-earlier period, the company more
-
Zentiva Profit Up 81% To RON32.4M In January-June
08.02.2016
Zentiva Bucharest (SCD.RO), a unit of France’s pharmaceutical group Sanofi, reported a net profit of RON32.4 million in January-June 2016, up 81% against the year-earlier period. more
-
Zentiva Profit Soared 68% To RON12M In 1Q/2016
05.18.2016
Zentiva Bucharest (SCD.RO), a unit of France’s pharmaceutical group Sanofi, reported a profit of RON12 million in January-March 2016, up 68% against the year-earlier period. more
-
Zentiva To Pay RON40M In Dividends For 2015
05.03.2016
Romanian drugmaker Zentiva Bucharest (SCD.RO), a unit of France’s pharmaceutical group Sanofi, will pay dividends totaling RON40 million for 2015, the company said in a statement. more
-
Zentiva Mulls Paying RON40M In Dividends For 2015
03.25.2016
Romanian drugmaker Zentiva Bucharest (SCD.RO), a unit of France’s pharmaceutical group Sanofi, wants to pay dividends of approximately RON0.0959 per share to shareholders, totaling RON40 million. more